Dr. Adam Maclauchlan, M.D
NPI: 1457702896
Total Payments
$3,616
2024 Payments
$1,258
Companies
39
Transactions
208
Medicare Patients
1,249
Medicare Billing
$100,540
Payment Breakdown by Category
Food & Beverage$3,550 (98.2%)
Education$65.99 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,550 | 207 | 98.2% |
| Education | $65.99 | 1 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $522.66 | 28 | $0 (2024) |
| ABBVIE INC. | $425.71 | 27 | $0 (2024) |
| GlaxoSmithKline, LLC. | $322.87 | 20 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $320.03 | 21 | $0 (2024) |
| Novo Nordisk Inc | $257.30 | 17 | $0 (2024) |
| Abbott Laboratories | $203.86 | 9 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $167.25 | 8 | $0 (2024) |
| Amgen Inc. | $135.17 | 9 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $123.07 | 8 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $114.09 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,258 | 69 | ABBVIE INC. ($161.00) |
| 2023 | $1,775 | 103 | Lilly USA, LLC ($264.55) |
| 2022 | $583.02 | 36 | Lilly USA, LLC ($150.38) |
All Payment Transactions
208 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Gastroenterology | ||||||
| 12/23/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Respiratory | ||||||
| 12/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Inflammation | ||||||
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: Respiratory | ||||||
| 12/12/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $28.71 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.63 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $23.54 | General |
| Category: UROLOGY | ||||||
| 11/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $19.45 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 10/10/2024 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Central Nervous System | ||||||
| 10/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Diabetes Care | ||||||
| 10/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Diabetes Care | ||||||
| 10/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Inflammation | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Respiratory | ||||||
| 09/27/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: UROLOGY | ||||||
| 09/20/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: SCHIZOPHRENIA | ||||||
| 09/19/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: Diabetes | ||||||
| 09/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Cardio-renal | ||||||
| 09/09/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Obesity | ||||||
| 09/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.04 | General |
| Category: Diabetes Care | ||||||
| 08/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Diabetes | ||||||
| 08/15/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 643 | 809 | $111,074 | $52,123 |
| 2022 | 6 | 347 | 435 | $66,669 | $27,139 |
| 2021 | 5 | 137 | 185 | $48,486 | $13,999 |
| 2020 | 4 | 122 | 152 | $24,093 | $7,279 |
Total Patients
1,249
Total Services
1,581
Medicare Billing
$100,540
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 157 | 275 | $50,325 | $23,284 | 46.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 264 | 307 | $39,603 | $18,074 | 45.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 36 | 36 | $5,400 | $4,544 | 84.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 45 | 45 | $7,155 | $2,455 | 34.3% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2023 | 33 | 34 | $3,400 | $1,578 | 46.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $2,607 | $1,296 | 49.7% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 35 | 35 | $1,225 | $633.15 | 51.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 17 | 17 | $918.00 | $150.57 | 16.4% |
| 81003 | Automated urinalysis test | Office | 2023 | 45 | 49 | $441.00 | $107.80 | 24.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 142 | 213 | $43,104 | $16,707 | 38.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 123 | 131 | $17,763 | $8,371 | 47.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 23 | 23 | $3,889 | $1,483 | 38.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 20 | 23 | $966.00 | $306.79 | 31.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 21 | 23 | $759.00 | $222.23 | 29.3% |
| 81003 | Automated urinalysis test | Office | 2022 | 18 | 22 | $188.00 | $48.61 | 25.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 68 | 113 | $24,408 | $9,223 | 37.8% |
| 45385 | Removal of polyps or growths in large bowel using an endoscope (colonoscopy) using a mechanical snare | Facility | 2021 | 15 | 15 | $18,855 | $2,883 | 15.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 25 | 26 | $4,056 | $1,532 | 37.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2021 | 16 | 16 | $672.00 | $214.24 | 31.9% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 13 | 15 | $495.00 | $145.65 | 29.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 53 | 76 | $16,416 | $5,065 | 30.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 40 | 41 | $6,396 | $1,844 | 28.8% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 17 | 21 | $693.00 | $198.18 | 28.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2020 | 12 | 14 | $588.00 | $172.88 | 29.4% |
About Dr. Adam Maclauchlan, M.D
Dr. Adam Maclauchlan, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Powhatan, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2016. The National Provider Identifier (NPI) number assigned to this provider is 1457702896.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Adam Maclauchlan, M.D has received a total of $3,616 in payments from pharmaceutical and medical device companies, with $1,258 received in 2024. These payments were reported across 208 transactions from 39 companies. The most common payment nature is "Food and Beverage" ($3,550).
As a Medicare-enrolled provider, Maclauchlan has provided services to 1,249 Medicare beneficiaries, totaling 1,581 services with total Medicare billing of $100,540. Data is available for 4 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine
- Location Powhatan, VA
- Active Since 06/27/2016
- Last Updated 08/28/2025
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1457702896
Products in Payments
- TRELEGY ELLIPTA (Drug) $246.33
- FREESTYLE LIBRE 3 (Device) $203.86
- UBRELVY (Drug) $186.31
- GEMTESA (Drug) $183.32
- EMGALITY (Drug) $178.01
- JARDIANCE (Drug) $177.09
- BREZTRI (Drug) $166.01
- TRULICITY (Drug) $157.84
- VRAYLAR (Drug) $143.84
- Otezla (Drug) $135.17
- MOUNJARO (Drug) $123.81
- Kerendia (Drug) $123.07
- Ozempic (Drug) $107.05
- TRINTELLIX (Drug) $99.72
- QULIPTA (Drug) $95.56
- NURTEC ODT (Drug) $91.13
- AIRSUPRA (Drug) $90.42
- Rybelsus (Drug) $83.27
- Auvelity (Drug) $69.17
- Wegovy (Drug) $66.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.